English

    Overview

  • Dr. Sudeep Das is a highly skilled and accomplished oncologist with over a decade of experience specialising in Medical Oncology and Haemato-oncology. Currently serving as a consultant in the Department of Medical Oncology at Manipal Hospitals E.M. Bypass, Kolkata, Dr. Das has built a reputation for his exceptional expertise and compassionate care. He has previously worked at renowned cancer centres, enhancing his proficiency in diagnosing and treating a wide range of malignancies. Dr. Das holds particular expertise in the management of gynaecological cancers, as well as Blood, Gastrointestinal, Musculoskeletal, Urological, and Head and neck malignancies.

  • Throughout his career, Dr. Das has remained dedicated to staying at the forefront of medical advancements in oncology. His involvement in professional organisations such as the Indian Society of Medical and Paediatric Oncology, the Association of Radiation Oncologists of India, and the European Society for Medical Oncology underscores his commitment to professional development and collaboration.

  • His tenure at Medica Superspecialty Hospital as a Senior Consultant further enriched his experience, enabling him to manage complex cancer cases with precision and empathy. With over ten years of experience in the field, Dr. Das continues to contribute significantly to the field of oncology, aiming to improve patient outcomes and quality of life.

  • Through his dedication to research and education, Dr. Sudeep Das has authored numerous articles that shed light on various aspects of oncology, thereby enriching the medical community's understanding of cancer treatment. His expertise is sought after by peers and organisations, making him a trusted figure in the field of oncology.

    • Fellowship & Membership

  • Member of the Indian Society of Medical and Paediatric Oncology.
  • Member of the Association of Radiation Oncologists of India.
  • Junior Member of the European Society for Medical Oncology.

    • Languages Spoken

  • English
  • Hindi
  • Bengali

    • Talks & Publications

  • Perioperative Modified FLOT Versus EOX in Locally Advanced Resectable Gastric and Gastro-Oesophageal Junction Adenocarcinoma: Results of a Matched-Pairs Analysis. Anant Ramaswamy 1. Prabhat Bhargava 1. Sujay Srinivas 1. Sadhana Kannan 2, Manish Bhandare 3. Vikram Chaudhan 3, Anoop Mantri 1, Akhil Kapoor 1, Sudeep Das 1, Naveen Booma 1. Deepali Chaugule 1. Sharlesh V Shrikhande 3, Vikas Ostwal. J Gastrointest Cancer. 2022 Oct 15. doi: 10.1007/s12029-022-00867- 3. Online ahead of print.
  • Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective audit. Bal Krishna Mishra, Akhil Kapoor, Aauj Gupta, Bipinesh Sansar, Arpita Singh, Somnath Roy. Tanmoy Mandal, Sujay Srinivas. Sudeep Das, Aseem Mishra, Ashutosh Mukherjee, Sambil Nanda and Kurupathy Sambasivatah, Ecancermedicalscience. 2022 Nov 2:16. 1460. doi 10.3332/ecancer, 2022, 1460. eCollection 2022.
  • An Analysis of Tolerance and Early Survival Outcomes with Perioperative Modified FLOT in Gastric Cancers. Prabhat Bhargava, Sudeep Das, Vikas Ostwal, Sujay Srinivas, Manish Bhandare, Vikram Chaudharı, Munita Bal, Anoop Mantri, Akhil Kapoor, Shailesh V Shrikhande. Ananı Ramaswamy. South Asian J Cancer 2022 Mar 22:11(2):112-117. doi: 10.1055/s-0041-1733349 eCollection 2022 Apr.
  • Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority. randomised, phase 3 trial. Vijay Patil. Vanita Noronha, Sachin Babanrao Dhumal, Amit Joshi, Nandini Menon, Atanu Bhattacharjee, Suyash Kulkarni, Suman Kumar Ankathi, Abhishek Mahajan, Nilesh Sable, Kavita Nawale, Arti Bhelekar, Sadaf Mukadam, Arun Chandrasekharan. Sudeep Das. Dilip Vallathol, Hollis D'Souza, Amit Kumar, Amit Agrawal, Satvik Khaddar. Narmadha Rathnasamy, Ramnath Shenoy, Lakhan Kashyap, Rahul Kumar Rai, George Abraham, Saswata Saha, Swaratika Majumdar, Naveen Karuvandan, Vijai Simha, Vasu Babu, Prahalad Flamarthi. Annu Rajpurohit, Kanteti Aditya Pavan Kumar, Anne Srikanth, Rahul Ravind, Shripad Banavali, Kumar Prabhash. Lancet Glob Health 2020; 8: e1213-22.
  • Thromboembolic events in brain tumour patients on bevacizumab, Gunjesh Kumar Singh, Nandini Menon, Monica Madhusing Jadhav, Rutuja Walavalkar, Hollis DSouza, Somnath Roy Sudeep Das, Sujay Srinivas, Dilip Harindran Vallathol, Vijay M Patil. Acta Oncol 2020 Dee:59(12):15343 1546. doi: 10.1080 0284186X.2020.1815834. Epub 2020 Sep 8.
  • Phase 1/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer. Patil VM, Noronha V, Joshi A, Dhumal S, Mahimkar M, Bhatacharjee A, Gota V, Pandey M. Menon N, Mahajan A, Sable N, Kumar S, Nawale K, Mukadam S, Solanki B, Das S, Simha V, Abraham G, Chandrasekharan A, Talreja V, DSouza H, Srinivas S, Kashyap 1., Banavali S, Prabhash K. J Clin Oncol, 2019 Sep 20: JCO1901076. doi: 10.1200/JC0,19.01076.
  • Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemeitabine Compared to Standard Dose Gemcitabine with Platinum in Advanced Squamous Lung Cancer, Patil V, Noronha N. Joshi A, Chougule A. Kannan S, Bhattacharjee A, Goud S, More S, Chandrasekharan A. Menon N Srinivas S. Vallathol DH, Dsouza H, Majumdar S, Das S, Zawar A. Khaddar S. Kumar A. Singh G Kumar KAP, Ravind R, Trivedi V, Behel V, Mahajan A. Janu A, Purandare N. Prabhash K EClinicalMedicine 9 (2019) 19-25.
  • Recurrent intracranial Rosai-Dorfman disease: Management of a challenging case. Das S, Biswas A, Roy S., Sable MN, Singh D, Jana M, Sharma MC, Julka PK. Asian J Neurosurg. 2017 Jul- Scp:12(3):537-540. doi: 10.4103/1793-5482.209994.
  • Outcome of primary orbital lymphoma treated with induction chemotherapy followed by conformal radiotherapy. Mallick S, Das S, Benson R, Roshan V, Bhasker S, J Egypt Natl Canc Inst 2015 Sep:27(3):1 13-7. doi: 10,1016/j.jnci,2015,04.003 Fpub 2015 Apr 29.
  • Rare sites of metastasis from gallbladder carcinoma, Mallick S, Roy S, Benson R, Das S, Julka PK. Rath GK, J Gastrointest Cancer, 2015 Mar:46(1):74-6. doi: 10.1007/s12029-014-9674-z.
  • Role of adjuvant radiation in the management of central neurocytoma: Experience from a tertiary cancer care centre of India. Mallick S, Roy S, Das S, Joshi N P, Roshan V, Gandhi A., Jana M, Julka K., Rath G K. Indian journal of cancer 2015 Oct-Dec;52(4):590-7, doi: 10.4 103/0019-509X.178378.

    Fellowship & Membership

  • Member of the Indian Society of Medical and Paediatric Oncology.
  • Member of the Association of Radiation Oncologists of India.
  • Junior Member of the European Society for Medical Oncology.

    • Overview

  • Dr. Sudeep Das is a highly skilled and accomplished oncologist with over a decade of experience specialising in Medical Oncology and Haemato-oncology. Currently serving as a consultant in the Department of Medical Oncology at Manipal Hospitals E.M. Bypass, Kolkata, Dr. Das has built a reputation for his exceptional expertise and compassionate care. He has previously worked at renowned cancer centres, enhancing his proficiency in diagnosing and treating a wide range of malignancies. Dr. Das holds particular expertise in the management of gynaecological cancers, as well as Blood, Gastrointestinal, Musculoskeletal, Urological, and Head and neck malignancies.

  • Throughout his career, Dr. Das has remained dedicated to staying at the forefront of medical advancements in oncology. His involvement in professional organisations such as the Indian Society of Medical and Paediatric Oncology, the Association of Radiation Oncologists of India, and the European Society for Medical Oncology underscores his commitment to professional development and collaboration.

  • His tenure at Medica Superspecialty Hospital as a Senior Consultant further enriched his experience, enabling him to manage complex cancer cases with precision and empathy. With over ten years of experience in the field, Dr. Das continues to contribute significantly to the field of oncology, aiming to improve patient outcomes and quality of life.

  • Through his dedication to research and education, Dr. Sudeep Das has authored numerous articles that shed light on various aspects of oncology, thereby enriching the medical community's understanding of cancer treatment. His expertise is sought after by peers and organisations, making him a trusted figure in the field of oncology.

    • Languages Spoken

  • English
  • Hindi
  • Bengali

    • Talks & Publications

  • Perioperative Modified FLOT Versus EOX in Locally Advanced Resectable Gastric and Gastro-Oesophageal Junction Adenocarcinoma: Results of a Matched-Pairs Analysis. Anant Ramaswamy 1. Prabhat Bhargava 1. Sujay Srinivas 1. Sadhana Kannan 2, Manish Bhandare 3. Vikram Chaudhan 3, Anoop Mantri 1, Akhil Kapoor 1, Sudeep Das 1, Naveen Booma 1. Deepali Chaugule 1. Sharlesh V Shrikhande 3, Vikas Ostwal. J Gastrointest Cancer. 2022 Oct 15. doi: 10.1007/s12029-022-00867- 3. Online ahead of print.
  • Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective audit. Bal Krishna Mishra, Akhil Kapoor, Aauj Gupta, Bipinesh Sansar, Arpita Singh, Somnath Roy. Tanmoy Mandal, Sujay Srinivas. Sudeep Das, Aseem Mishra, Ashutosh Mukherjee, Sambil Nanda and Kurupathy Sambasivatah, Ecancermedicalscience. 2022 Nov 2:16. 1460. doi 10.3332/ecancer, 2022, 1460. eCollection 2022.
  • An Analysis of Tolerance and Early Survival Outcomes with Perioperative Modified FLOT in Gastric Cancers. Prabhat Bhargava, Sudeep Das, Vikas Ostwal, Sujay Srinivas, Manish Bhandare, Vikram Chaudharı, Munita Bal, Anoop Mantri, Akhil Kapoor, Shailesh V Shrikhande. Ananı Ramaswamy. South Asian J Cancer 2022 Mar 22:11(2):112-117. doi: 10.1055/s-0041-1733349 eCollection 2022 Apr.
  • Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority. randomised, phase 3 trial. Vijay Patil. Vanita Noronha, Sachin Babanrao Dhumal, Amit Joshi, Nandini Menon, Atanu Bhattacharjee, Suyash Kulkarni, Suman Kumar Ankathi, Abhishek Mahajan, Nilesh Sable, Kavita Nawale, Arti Bhelekar, Sadaf Mukadam, Arun Chandrasekharan. Sudeep Das. Dilip Vallathol, Hollis D'Souza, Amit Kumar, Amit Agrawal, Satvik Khaddar. Narmadha Rathnasamy, Ramnath Shenoy, Lakhan Kashyap, Rahul Kumar Rai, George Abraham, Saswata Saha, Swaratika Majumdar, Naveen Karuvandan, Vijai Simha, Vasu Babu, Prahalad Flamarthi. Annu Rajpurohit, Kanteti Aditya Pavan Kumar, Anne Srikanth, Rahul Ravind, Shripad Banavali, Kumar Prabhash. Lancet Glob Health 2020; 8: e1213-22.
  • Thromboembolic events in brain tumour patients on bevacizumab, Gunjesh Kumar Singh, Nandini Menon, Monica Madhusing Jadhav, Rutuja Walavalkar, Hollis DSouza, Somnath Roy Sudeep Das, Sujay Srinivas, Dilip Harindran Vallathol, Vijay M Patil. Acta Oncol 2020 Dee:59(12):15343 1546. doi: 10.1080 0284186X.2020.1815834. Epub 2020 Sep 8.
  • Phase 1/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer. Patil VM, Noronha V, Joshi A, Dhumal S, Mahimkar M, Bhatacharjee A, Gota V, Pandey M. Menon N, Mahajan A, Sable N, Kumar S, Nawale K, Mukadam S, Solanki B, Das S, Simha V, Abraham G, Chandrasekharan A, Talreja V, DSouza H, Srinivas S, Kashyap 1., Banavali S, Prabhash K. J Clin Oncol, 2019 Sep 20: JCO1901076. doi: 10.1200/JC0,19.01076.
  • Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemeitabine Compared to Standard Dose Gemcitabine with Platinum in Advanced Squamous Lung Cancer, Patil V, Noronha N. Joshi A, Chougule A. Kannan S, Bhattacharjee A, Goud S, More S, Chandrasekharan A. Menon N Srinivas S. Vallathol DH, Dsouza H, Majumdar S, Das S, Zawar A. Khaddar S. Kumar A. Singh G Kumar KAP, Ravind R, Trivedi V, Behel V, Mahajan A. Janu A, Purandare N. Prabhash K EClinicalMedicine 9 (2019) 19-25.
  • Recurrent intracranial Rosai-Dorfman disease: Management of a challenging case. Das S, Biswas A, Roy S., Sable MN, Singh D, Jana M, Sharma MC, Julka PK. Asian J Neurosurg. 2017 Jul- Scp:12(3):537-540. doi: 10.4103/1793-5482.209994.
  • Outcome of primary orbital lymphoma treated with induction chemotherapy followed by conformal radiotherapy. Mallick S, Das S, Benson R, Roshan V, Bhasker S, J Egypt Natl Canc Inst 2015 Sep:27(3):1 13-7. doi: 10,1016/j.jnci,2015,04.003 Fpub 2015 Apr 29.
  • Rare sites of metastasis from gallbladder carcinoma, Mallick S, Roy S, Benson R, Das S, Julka PK. Rath GK, J Gastrointest Cancer, 2015 Mar:46(1):74-6. doi: 10.1007/s12029-014-9674-z.
  • Role of adjuvant radiation in the management of central neurocytoma: Experience from a tertiary cancer care centre of India. Mallick S, Roy S, Das S, Joshi N P, Roshan V, Gandhi A., Jana M, Julka K., Rath G K. Indian journal of cancer 2015 Oct-Dec;52(4):590-7, doi: 10.4 103/0019-509X.178378.

    Languages Spoken

  • English
  • Hindi
  • Bengali

    • Overview

  • Dr. Sudeep Das is a highly skilled and accomplished oncologist with over a decade of experience specialising in Medical Oncology and Haemato-oncology. Currently serving as a consultant in the Department of Medical Oncology at Manipal Hospitals E.M. Bypass, Kolkata, Dr. Das has built a reputation for his exceptional expertise and compassionate care. He has previously worked at renowned cancer centres, enhancing his proficiency in diagnosing and treating a wide range of malignancies. Dr. Das holds particular expertise in the management of gynaecological cancers, as well as Blood, Gastrointestinal, Musculoskeletal, Urological, and Head and neck malignancies.

  • Throughout his career, Dr. Das has remained dedicated to staying at the forefront of medical advancements in oncology. His involvement in professional organisations such as the Indian Society of Medical and Paediatric Oncology, the Association of Radiation Oncologists of India, and the European Society for Medical Oncology underscores his commitment to professional development and collaboration.

  • His tenure at Medica Superspecialty Hospital as a Senior Consultant further enriched his experience, enabling him to manage complex cancer cases with precision and empathy. With over ten years of experience in the field, Dr. Das continues to contribute significantly to the field of oncology, aiming to improve patient outcomes and quality of life.

  • Through his dedication to research and education, Dr. Sudeep Das has authored numerous articles that shed light on various aspects of oncology, thereby enriching the medical community's understanding of cancer treatment. His expertise is sought after by peers and organisations, making him a trusted figure in the field of oncology.

    • Fellowship & Membership

  • Member of the Indian Society of Medical and Paediatric Oncology.
  • Member of the Association of Radiation Oncologists of India.
  • Junior Member of the European Society for Medical Oncology.

    • Talks & Publications

  • Perioperative Modified FLOT Versus EOX in Locally Advanced Resectable Gastric and Gastro-Oesophageal Junction Adenocarcinoma: Results of a Matched-Pairs Analysis. Anant Ramaswamy 1. Prabhat Bhargava 1. Sujay Srinivas 1. Sadhana Kannan 2, Manish Bhandare 3. Vikram Chaudhan 3, Anoop Mantri 1, Akhil Kapoor 1, Sudeep Das 1, Naveen Booma 1. Deepali Chaugule 1. Sharlesh V Shrikhande 3, Vikas Ostwal. J Gastrointest Cancer. 2022 Oct 15. doi: 10.1007/s12029-022-00867- 3. Online ahead of print.
  • Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective audit. Bal Krishna Mishra, Akhil Kapoor, Aauj Gupta, Bipinesh Sansar, Arpita Singh, Somnath Roy. Tanmoy Mandal, Sujay Srinivas. Sudeep Das, Aseem Mishra, Ashutosh Mukherjee, Sambil Nanda and Kurupathy Sambasivatah, Ecancermedicalscience. 2022 Nov 2:16. 1460. doi 10.3332/ecancer, 2022, 1460. eCollection 2022.
  • An Analysis of Tolerance and Early Survival Outcomes with Perioperative Modified FLOT in Gastric Cancers. Prabhat Bhargava, Sudeep Das, Vikas Ostwal, Sujay Srinivas, Manish Bhandare, Vikram Chaudharı, Munita Bal, Anoop Mantri, Akhil Kapoor, Shailesh V Shrikhande. Ananı Ramaswamy. South Asian J Cancer 2022 Mar 22:11(2):112-117. doi: 10.1055/s-0041-1733349 eCollection 2022 Apr.
  • Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority. randomised, phase 3 trial. Vijay Patil. Vanita Noronha, Sachin Babanrao Dhumal, Amit Joshi, Nandini Menon, Atanu Bhattacharjee, Suyash Kulkarni, Suman Kumar Ankathi, Abhishek Mahajan, Nilesh Sable, Kavita Nawale, Arti Bhelekar, Sadaf Mukadam, Arun Chandrasekharan. Sudeep Das. Dilip Vallathol, Hollis D'Souza, Amit Kumar, Amit Agrawal, Satvik Khaddar. Narmadha Rathnasamy, Ramnath Shenoy, Lakhan Kashyap, Rahul Kumar Rai, George Abraham, Saswata Saha, Swaratika Majumdar, Naveen Karuvandan, Vijai Simha, Vasu Babu, Prahalad Flamarthi. Annu Rajpurohit, Kanteti Aditya Pavan Kumar, Anne Srikanth, Rahul Ravind, Shripad Banavali, Kumar Prabhash. Lancet Glob Health 2020; 8: e1213-22.
  • Thromboembolic events in brain tumour patients on bevacizumab, Gunjesh Kumar Singh, Nandini Menon, Monica Madhusing Jadhav, Rutuja Walavalkar, Hollis DSouza, Somnath Roy Sudeep Das, Sujay Srinivas, Dilip Harindran Vallathol, Vijay M Patil. Acta Oncol 2020 Dee:59(12):15343 1546. doi: 10.1080 0284186X.2020.1815834. Epub 2020 Sep 8.
  • Phase 1/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer. Patil VM, Noronha V, Joshi A, Dhumal S, Mahimkar M, Bhatacharjee A, Gota V, Pandey M. Menon N, Mahajan A, Sable N, Kumar S, Nawale K, Mukadam S, Solanki B, Das S, Simha V, Abraham G, Chandrasekharan A, Talreja V, DSouza H, Srinivas S, Kashyap 1., Banavali S, Prabhash K. J Clin Oncol, 2019 Sep 20: JCO1901076. doi: 10.1200/JC0,19.01076.
  • Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemeitabine Compared to Standard Dose Gemcitabine with Platinum in Advanced Squamous Lung Cancer, Patil V, Noronha N. Joshi A, Chougule A. Kannan S, Bhattacharjee A, Goud S, More S, Chandrasekharan A. Menon N Srinivas S. Vallathol DH, Dsouza H, Majumdar S, Das S, Zawar A. Khaddar S. Kumar A. Singh G Kumar KAP, Ravind R, Trivedi V, Behel V, Mahajan A. Janu A, Purandare N. Prabhash K EClinicalMedicine 9 (2019) 19-25.
  • Recurrent intracranial Rosai-Dorfman disease: Management of a challenging case. Das S, Biswas A, Roy S., Sable MN, Singh D, Jana M, Sharma MC, Julka PK. Asian J Neurosurg. 2017 Jul- Scp:12(3):537-540. doi: 10.4103/1793-5482.209994.
  • Outcome of primary orbital lymphoma treated with induction chemotherapy followed by conformal radiotherapy. Mallick S, Das S, Benson R, Roshan V, Bhasker S, J Egypt Natl Canc Inst 2015 Sep:27(3):1 13-7. doi: 10,1016/j.jnci,2015,04.003 Fpub 2015 Apr 29.
  • Rare sites of metastasis from gallbladder carcinoma, Mallick S, Roy S, Benson R, Das S, Julka PK. Rath GK, J Gastrointest Cancer, 2015 Mar:46(1):74-6. doi: 10.1007/s12029-014-9674-z.
  • Role of adjuvant radiation in the management of central neurocytoma: Experience from a tertiary cancer care centre of India. Mallick S, Roy S, Das S, Joshi N P, Roshan V, Gandhi A., Jana M, Julka K., Rath G K. Indian journal of cancer 2015 Oct-Dec;52(4):590-7, doi: 10.4 103/0019-509X.178378.

    Talks & Publications

  • Perioperative Modified FLOT Versus EOX in Locally Advanced Resectable Gastric and Gastro-Oesophageal Junction Adenocarcinoma: Results of a Matched-Pairs Analysis. Anant Ramaswamy 1. Prabhat Bhargava 1. Sujay Srinivas 1. Sadhana Kannan 2, Manish Bhandare 3. Vikram Chaudhan 3, Anoop Mantri 1, Akhil Kapoor 1, Sudeep Das 1, Naveen Booma 1. Deepali Chaugule 1. Sharlesh V Shrikhande 3, Vikas Ostwal. J Gastrointest Cancer. 2022 Oct 15. doi: 10.1007/s12029-022-00867- 3. Online ahead of print.
  • Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective audit. Bal Krishna Mishra, Akhil Kapoor, Aauj Gupta, Bipinesh Sansar, Arpita Singh, Somnath Roy. Tanmoy Mandal, Sujay Srinivas. Sudeep Das, Aseem Mishra, Ashutosh Mukherjee, Sambil Nanda and Kurupathy Sambasivatah, Ecancermedicalscience. 2022 Nov 2:16. 1460. doi 10.3332/ecancer, 2022, 1460. eCollection 2022.
  • An Analysis of Tolerance and Early Survival Outcomes with Perioperative Modified FLOT in Gastric Cancers. Prabhat Bhargava, Sudeep Das, Vikas Ostwal, Sujay Srinivas, Manish Bhandare, Vikram Chaudharı, Munita Bal, Anoop Mantri, Akhil Kapoor, Shailesh V Shrikhande. Ananı Ramaswamy. South Asian J Cancer 2022 Mar 22:11(2):112-117. doi: 10.1055/s-0041-1733349 eCollection 2022 Apr.
  • Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority. randomised, phase 3 trial. Vijay Patil. Vanita Noronha, Sachin Babanrao Dhumal, Amit Joshi, Nandini Menon, Atanu Bhattacharjee, Suyash Kulkarni, Suman Kumar Ankathi, Abhishek Mahajan, Nilesh Sable, Kavita Nawale, Arti Bhelekar, Sadaf Mukadam, Arun Chandrasekharan. Sudeep Das. Dilip Vallathol, Hollis D'Souza, Amit Kumar, Amit Agrawal, Satvik Khaddar. Narmadha Rathnasamy, Ramnath Shenoy, Lakhan Kashyap, Rahul Kumar Rai, George Abraham, Saswata Saha, Swaratika Majumdar, Naveen Karuvandan, Vijai Simha, Vasu Babu, Prahalad Flamarthi. Annu Rajpurohit, Kanteti Aditya Pavan Kumar, Anne Srikanth, Rahul Ravind, Shripad Banavali, Kumar Prabhash. Lancet Glob Health 2020; 8: e1213-22.
  • Thromboembolic events in brain tumour patients on bevacizumab, Gunjesh Kumar Singh, Nandini Menon, Monica Madhusing Jadhav, Rutuja Walavalkar, Hollis DSouza, Somnath Roy Sudeep Das, Sujay Srinivas, Dilip Harindran Vallathol, Vijay M Patil. Acta Oncol 2020 Dee:59(12):15343 1546. doi: 10.1080 0284186X.2020.1815834. Epub 2020 Sep 8.
  • Phase 1/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer. Patil VM, Noronha V, Joshi A, Dhumal S, Mahimkar M, Bhatacharjee A, Gota V, Pandey M. Menon N, Mahajan A, Sable N, Kumar S, Nawale K, Mukadam S, Solanki B, Das S, Simha V, Abraham G, Chandrasekharan A, Talreja V, DSouza H, Srinivas S, Kashyap 1., Banavali S, Prabhash K. J Clin Oncol, 2019 Sep 20: JCO1901076. doi: 10.1200/JC0,19.01076.
  • Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemeitabine Compared to Standard Dose Gemcitabine with Platinum in Advanced Squamous Lung Cancer, Patil V, Noronha N. Joshi A, Chougule A. Kannan S, Bhattacharjee A, Goud S, More S, Chandrasekharan A. Menon N Srinivas S. Vallathol DH, Dsouza H, Majumdar S, Das S, Zawar A. Khaddar S. Kumar A. Singh G Kumar KAP, Ravind R, Trivedi V, Behel V, Mahajan A. Janu A, Purandare N. Prabhash K EClinicalMedicine 9 (2019) 19-25.
  • Recurrent intracranial Rosai-Dorfman disease: Management of a challenging case. Das S, Biswas A, Roy S., Sable MN, Singh D, Jana M, Sharma MC, Julka PK. Asian J Neurosurg. 2017 Jul- Scp:12(3):537-540. doi: 10.4103/1793-5482.209994.
  • Outcome of primary orbital lymphoma treated with induction chemotherapy followed by conformal radiotherapy. Mallick S, Das S, Benson R, Roshan V, Bhasker S, J Egypt Natl Canc Inst 2015 Sep:27(3):1 13-7. doi: 10,1016/j.jnci,2015,04.003 Fpub 2015 Apr 29.
  • Rare sites of metastasis from gallbladder carcinoma, Mallick S, Roy S, Benson R, Das S, Julka PK. Rath GK, J Gastrointest Cancer, 2015 Mar:46(1):74-6. doi: 10.1007/s12029-014-9674-z.
  • Role of adjuvant radiation in the management of central neurocytoma: Experience from a tertiary cancer care centre of India. Mallick S, Roy S, Das S, Joshi N P, Roshan V, Gandhi A., Jana M, Julka K., Rath G K. Indian journal of cancer 2015 Oct-Dec;52(4):590-7, doi: 10.4 103/0019-509X.178378.

    • Overview

  • Dr. Sudeep Das is a highly skilled and accomplished oncologist with over a decade of experience specialising in Medical Oncology and Haemato-oncology. Currently serving as a consultant in the Department of Medical Oncology at Manipal Hospitals E.M. Bypass, Kolkata, Dr. Das has built a reputation for his exceptional expertise and compassionate care. He has previously worked at renowned cancer centres, enhancing his proficiency in diagnosing and treating a wide range of malignancies. Dr. Das holds particular expertise in the management of gynaecological cancers, as well as Blood, Gastrointestinal, Musculoskeletal, Urological, and Head and neck malignancies.

  • Throughout his career, Dr. Das has remained dedicated to staying at the forefront of medical advancements in oncology. His involvement in professional organisations such as the Indian Society of Medical and Paediatric Oncology, the Association of Radiation Oncologists of India, and the European Society for Medical Oncology underscores his commitment to professional development and collaboration.

  • His tenure at Medica Superspecialty Hospital as a Senior Consultant further enriched his experience, enabling him to manage complex cancer cases with precision and empathy. With over ten years of experience in the field, Dr. Das continues to contribute significantly to the field of oncology, aiming to improve patient outcomes and quality of life.

  • Through his dedication to research and education, Dr. Sudeep Das has authored numerous articles that shed light on various aspects of oncology, thereby enriching the medical community's understanding of cancer treatment. His expertise is sought after by peers and organisations, making him a trusted figure in the field of oncology.

    • Fellowship & Membership

  • Member of the Indian Society of Medical and Paediatric Oncology.
  • Member of the Association of Radiation Oncologists of India.
  • Junior Member of the European Society for Medical Oncology.

    • Languages Spoken

  • English
  • Hindi
  • Bengali

FAQ's

Patients often seek Dr. Sudeep Das’s expertise as the Consultant - Medical Oncology at Manipal Hospitals EM Bypass. Dr. Sudeep Das, Best Medical Oncologist in EM Bypass, Kolkata. Expert in Blood Disorders, Leukemia & Lymphoma Treatment. Trusted Care. Book Appointment Today!

Home Em-bypass Doctors Dr-sudeep-das-medical-oncologist

Appointment
Health Check
Contact Us
review icon
Review Us
Call Us